Covered recipient · General Payments record
MELISSA MAXINE BURKE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$667.98
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $326.91 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $81.82 | 4 |
| Novo Nordisk AS | $67.48 | 4 |
| Exact Sciences Corporation | $59.79 | 4 |
| Amgen Inc. | $52.42 | 3 |
| Lilly USA, LLC | $47.30 | 3 |
| PFIZER INC. | $18.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $17.46 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117213886 | CMS |
| Amgen Inc. | $17.17 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117213888 | CMS |
| Amgen Inc. | $17.79 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115469989 | CMS |
| Exact Sciences Corporation | $15.80 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114531198 | CMS |
| Exact Sciences Corporation | $14.72 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114531202 | CMS |
| Exact Sciences Corporation | $14.89 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114531206 | CMS |
| Exact Sciences Corporation | $14.38 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114531210 | CMS |
| GlaxoSmithKline, LLC. | $14.45 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116570499 | CMS |
| GlaxoSmithKline, LLC. | $27.45 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115836259 | CMS |
| GlaxoSmithKline, LLC. | $19.89 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116382420 | CMS |
| GlaxoSmithKline, LLC. | $20.03 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116612900 | CMS |
| Lilly USA, LLC | $14.79 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135189189 | CMS |
| Lilly USA, LLC | $17.05 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135189265 | CMS |
| Lilly USA, LLC | $15.46 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135221916 | CMS |
| Novo Nordisk Inc | $13.32 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097189477 | CMS |
| Novo Nordisk Inc | $19.97 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096596796 | CMS |
| Novo Nordisk Inc | $18.55 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096949922 | CMS |
| Novo Nordisk Inc | $15.64 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097815916 | CMS |
| PFIZER INC. | $18.10 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132003075 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.